Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022

Latest Articles

  • You have access
    Vertebral compression fractures: What time destroys, methylmethacrylate may mend
    Christopher M. Bono, MD
    Cleveland Clinic Journal of Medicine February 2003, 70 (2) 88-90;

    The sequelae of osteoporosis present numerous clinical challenges; several new surgical options show promise.

  • Vertebral compression fractures: Manage aggressively to prevent sequelae
    You have access
    Vertebral compression fractures: Manage aggressively to prevent sequelae
    Daniel J. Mazanec, MD, Vinod K. Podichetty, MD, Alex Mompoint, MD and Amarish Potnis, MD
    Cleveland Clinic Journal of Medicine February 2003, 70 (2) 147-156;

    Advances in preventing and managing acute vertebral compression fractures can reduce their devastating impact, even in the face of an aging population.

  • You have access
    Pre-event smallpox vaccination: Unresolved issues
    Steven M. Gordon, MD
    Cleveland Clinic Journal of Medicine February 2003, 70 (2) 80-86;

    We are on the verge of the first phase of nationwide smallpox vaccination, but many questions remain unanswered.

  • You have access
    Challenges and choices in drug therapy for chronic pain
    Scott M. Fishman, MD and David Teichera, MD
    Cleveland Clinic Journal of Medicine February 2003, 70 (2) 119-138;

    Chronic pain is different from acute pain, and its treatment is more challenging.

  • What are the key issues women face when ending hormone replacement therapy?
    You have access
    What are the key issues women face when ending hormone replacement therapy?
    Wulf H. Utian, MD, BCH, PhD
    Cleveland Clinic Journal of Medicine February 2003, 70 (2) 93-94;

    A logical approach is to review why the patient is on HRT and to consider alternatives.

  • Migraine treatments– what you can expect
    You have access
    Migraine treatments– what you can expect
    Cleveland Clinic Journal of Medicine January 2003, 70 (1) 30;
  • You have access
    Cyber-CME and the Journal’s computer-literate readers
    John D. Clough, MD
    Cleveland Clinic Journal of Medicine January 2003, 70 (1) 7;

    Congratulations to you, our readers, on your adaptability and computer literacy.

  • You have access
    A 62-year-old man with sudden onset of orthopnea and left shoulder weakness and pain
    William C. Cook, DO and Jeffrey Chapman, MD
    Cleveland Clinic Journal of Medicine January 2003, 70 (1) 66-69;

    What is the cause of this patient’s symptoms? A self-test.

  • Alosetron (Lotronex) is back: Should I use it to treat my patients with irritable bowel syndrome?
    You have access
    Alosetron (Lotronex) is back: Should I use it to treat my patients with irritable bowel syndrome?
    Bo Shen, MD and Edy E. Soffer, MD
    Cleveland Clinic Journal of Medicine January 2003, 70 (1) 64-65;

    The FDA recently approved the remarketing of alosetron, but with strict limitations.

  • If your tuberculosis skin test is positive
    You have access
    If your tuberculosis skin test is positive
    Cleveland Clinic Journal of Medicine January 2003, 70 (1) 56;

Pages

  • Previous
  • Next
  • 1
  • …
  • 372
  • 373
  • 374
  • 375
  • 376
  • 377
  • 378
  • 379
  • 380
  • …
  • 799

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire